Literature DB >> 17255841

Efficacy of rice-based oral rehydration solution containing recombinant human lactoferrin and lysozyme in Peruvian children with acute diarrhea.

Nelly Zavaleta1, Dante Figueroa, Juan Rivera, Julia Sánchez, Segundo Alfaro, Bo Lönnerdal.   

Abstract

OBJECTIVE: To compare glucose and rice-based oral rehydration solution with rice-based oral rehydration solution containing recombinant human lactoferrin and recombinant human lysozyme in diarrhea outcomes. PATIENTS AND METHODS: We conducted a randomized, double-blind controlled trial in children with acute diarrhea and dehydration. One hundred and forty children 5 to 33 months old were block randomized to receive low osmolarity WHO-ORS (G-ORS), rice-based ORS (R-ORS), or rice-based ORS plus lactoferrin and lysozyme (Lf/Lz-R-ORS). Intake and output were monitored for 48 h in the ORU, with continued monitoring through home and clinic follow-up for 14 d.
RESULTS: The G-ORS and R-ORS groups did not show any differences in diarrhea outcomes and were therefore combined as the control group. Intent-to-treat analysis showed a significant decrease in duration of diarrhea (3.67 d vs 5.21 d, P = 0.05) in the Lf/Lz-R-ORS group as compared with the control group and a significant increase in the number of children who achieved 48 h with solid stool, 85% vs 69% (P < 0.05). There were no significant differences [corrected] in volume of diarrhea or [corrected] the percentage of children who had a new diarrhea episode after achieving the endpoint.
CONCLUSIONS: Addition of recombinant human lactoferrin and lysozyme to a rice-based oral rehydration solution had beneficial effects on children with acute diarrhea.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255841     DOI: 10.1097/MPG.0b013e31802c41b7

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  29 in total

1.  A semi-quantitative approach to GMO risk-benefit analysis.

Authors:  E Jane Morris
Journal:  Transgenic Res       Date:  2011-01-01       Impact factor: 2.788

2.  Impact of lactoferrin supplementation on growth and prevalence of Giardia colonization in children.

Authors:  Theresa J Ochoa; Elsa Chea-Woo; Miguel Campos; Iris Pecho; Ana Prada; Robert J McMahon; Thomas G Cleary
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

Review 3.  Immunomodulatory effects of lactoferrin.

Authors:  Tania Siqueiros-Cendón; Sigifredo Arévalo-Gallegos; Blanca Flor Iglesias-Figueroa; Isui Abril García-Montoya; José Salazar-Martínez; Quintín Rascón-Cruz
Journal:  Acta Pharmacol Sin       Date:  2014-05       Impact factor: 6.150

Review 4.  Nutrigenomics and personalized diets: What will they mean for food?

Authors:  J Bruce German; Angela M Zivkovic; David C Dallas; Jennifer T Smilowitz
Journal:  Annu Rev Food Sci Technol       Date:  2011

5.  Randomized double-blind controlled trial of bovine lactoferrin for prevention of diarrhea in children.

Authors:  Theresa J Ochoa; Elsa Chea-Woo; Nelly Baiocchi; Iris Pecho; Miguel Campos; Ana Prada; Gladys Valdiviezo; Angela Lluque; Dejian Lai; Thomas G Cleary
Journal:  J Pediatr       Date:  2012-08-30       Impact factor: 4.406

6.  Enteral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates.

Authors:  Mohan Pammi; Steven A Abrams
Journal:  Cochrane Database Syst Rev       Date:  2019-05-11

Review 7.  Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients.

Authors:  Sandeep K Mallipattu; John C He; Jaime Uribarri
Journal:  Semin Dial       Date:  2012-04-30       Impact factor: 3.455

8.  Enteroaggregative Escherichia coli: An Emerging Enteric Food Borne Pathogen.

Authors:  P Kaur; A Chakraborti; A Asea
Journal:  Interdiscip Perspect Infect Dis       Date:  2010-03-11

Review 9.  Effect of lactoferrin on enteric pathogens.

Authors:  Theresa J Ochoa; Thomas G Cleary
Journal:  Biochimie       Date:  2008-04-18       Impact factor: 4.079

10.  Improving the ORS: does glutamine have a role?

Authors:  Pradip K Bardhan
Journal:  J Health Popul Nutr       Date:  2007-09       Impact factor: 2.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.